Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Improving the referral process for familial breast cancer genetic counselling: an evaluation of complementary interventions
ISRCTN ISRCTN60569158
ClinicalTrials.gov identifier
Public title Improving the referral process for familial breast cancer genetic counselling: an evaluation of complementary interventions
Scientific title
Acronym N/A
Serial number at source HTA 94/14/20
Study hypothesis The NHS needs to identify cost-effective approaches to managing the increased demand for genetic counselling for familial cancers, particularly in the primary care setting. Using familial breast cancer as a model, this study aims to evaluate two separate, but complementary, interventions using randomised controlled trials: the first designed to improve the process of deciding to refer from primary care to specialist services, the second to cope with referred women in a cost-effective way in the community. In the first trial, general practices in Grampian will be randomised to receive specific educational input for a member of their staff, along with specific decision-support software, or to no intervention (control): outcomes will relate to appropriateness of referrals and patient understanding, In the second trial, based in Grampian and Wales, referred women will be randomised either to see a community-based genetics outreach nurse or to the current, specialist service: comparisons will be made of psychological outcomes and retention of risk information, and service acceptability to patients and professionals. An economic evaluation is an integral component of each trial.
Lay summary
Ethics approval Not provided at time of registration
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Cancer (neoplasms): Breast
Participants - inclusion criteria Women with familial breast cancer in need of genetic counselling
Participants - exclusion criteria Not provided at time of registration
Anticipated start date 01/02/1998
Anticipated end date 31/08/2002
Status of trial Completed
Patient information material
Target number of participants Not provided at time of registration
Interventions Trial 1:
1. Receive specific educational input for a member of their staff, along with specific decision-support software
2. Standard care.

Trial 2: Referred women will be randomised to see
1. A community-based genetics outreach nurse
2. Remain on current specialist service
Primary outcome measure(s) Not provided at time of registration
Secondary outcome measure(s) Not provided at time of registration
Sources of funding NIHR Health Technology Assessment Programme - HTA (UK)
Trial website
Publications 1. 2005 results in http://www.ncbi.nlm.nih.gov/pubmed/15694064
Contact name Dr  Brenda  Wilson
  Address Department of Epidemiology & Community Medicine
University of Ottawa
451 Smyth Road
Ottawa
  City/town Ontario
  Zip/Postcode K1H 8M5
  Country Canada
  Tel +1 613 562 5800 x8261
  Fax +1 613 562 5645
  Email bwilson@uottawa.ca
Sponsor Department of Health (UK)
  Address Quarry House
Quarry Hill
  City/town Leeds
  Zip/Postcode LS2 7UE
  Country United Kingdom
  Tel +44 (0)1132 545 843
  Email Sheila.Greener@doh.gsi.gov.uk
  Sponsor website: http://www.dh.gov.uk/en/index.htm
Date applied 25/04/2003
Last edited 27/10/2010
Date ISRCTN assigned 25/04/2003
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central